Literature DB >> 9918360

Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.

I H Richard1, A Maughn, R Kurlan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9918360     DOI： 10.1002/1531-8257(199901)14:1<155::aid-mds1026>3.0.co;2-z

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  14 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Depression in Parkinson's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

3.  Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

Authors:  D A M C van de Vijver; R A C Roos; P A F Jansen; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

4.  Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.

Authors:  Alberto J Espay; Joe P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Emily Dunn; Jennifer E Vaughan; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Dustin A Heldman
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

Review 5.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

6.  Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.

Authors:  Maurits E L Arbouw; Kris L L Movig; Cees Neef; Henk-Jan Guchelaar; Toine C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2007-01-03       Impact factor: 2.953

Review 7.  Depression in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 8.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

9.  Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.

Authors:  Paolo Barone; Leonardo Scarzella; Roberto Marconi; Angelo Antonini; Letterio Morgante; Fulvio Bracco; Mario Zappia; Bruno Musch
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

Review 10.  Depression and Parkinson's disease.

Authors:  Matthias R Lemke; Gerd Fuchs; Irene Gemende; Birgit Herting; Christian Oehlwein; Heinz Reichmann; Jürgen Rieke; Jens Volkmann
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.